SecBot SecBot
SC 13G/A ·Filed Oct 27, 2026

XNCR

Xencor Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 17h ago SEC0002012383-26-003865
Passive stake amendment
Actionable Insight • Neutral

BlackRock's passive stake remains stable at 14.5%. No change in position or intent signals a routine update. Monitor for any future conversion to Schedule 13D or significant share reductions, which would indicate a shift in sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+1d
XNCR ▼ -2.60% at T+1d
NEUTRAL call -2.60% · α vs SPY -2.22% · entry $29.99 → $29.21
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 27, 2026
via day close
T+1d
-2.60%
call -2.60% · α -2.22%
$29.21
settled 4d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 23d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

BlackRock Inc. filed an amended Schedule 13G for Xencor Inc, disclosing beneficial ownership of 10,816,417 shares (14.5% of common stock) as of September 30, 2026. This is a routine passive stake update by a large index/asset manager; no change in investment intent is indicated.

Key Financial Metrics

Stake
14.5%
Investor
BlackRock, Inc.
Investor Type
mutual fund

Key Facts

  • BlackRock reported beneficial ownership of 10,816,417 shares of Xencor common stock, representing 14.5% of outstanding shares.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
  • The stake is held across multiple BlackRock subsidiaries, with BlackRock Fund Advisors noted as the entity owning 5% or more.
  • One BlackRock-managed fund, iShares Core S&P Small-Cap ETF, holds more than 5% of Xencor's common stock.
  • The filing date is October 27, 2026, with a beneficial ownership date of September 30, 2026.

Financial Impact

BlackRock's 14.5% stake represents approximately $275.5 million based on a $1.9B market cap.

ownership_percentage

Risk Factors

  • No specific risks identified; this is a routine passive ownership disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0002012383-26-003865
Document: Item_7.txt0002012383-26-003865
Document: 0002012383-26-003865-index-headers.html0002012383-26-003865
Document: 0002012383-26-003865-index.html0002012383-26-003865
Document: 0002012383-26-003865.txt0002012383-26-003865
13 reports for XNCR
Performance horizon
50% Hit rate @ T+1 3 of 6 directional calls Went positive at some point 4 of 6 best @ T+60▲ +67.24%May 5, 2026
Filters
Rows
Reports for XNCR, sortable and filterable
TypeNow
Oct 30, 2026
1d ago
SC 13G/A
BEARISH ★ 4/10
$29.09awaiting T+1awaiting T+1$29.82 (−2.51%)
Oct 27, 2026
4d ago
SC 13G/A
NEUTRAL ★ 2/10
$29.99 $29.21▼ −2.60%▼ −2.22%$29.82 (−0.57%)
Oct 26, 2026
6d ago
8-K
BULLISH ★ 6/10
$29.18 $29.99▲ +2.78%▲ +2.22%$29.82 (+2.19%)
Aug 5, 2026
12w ago
8-K
BULLISH ★ 7/10
$20.00 $20.81▲ +4.05%▲ +3.44%$29.82 (+49.10%)
Jun 17, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$12.64 $14.01▲ +10.84%▲ +11.15%$29.82 (+135.92%)
Jun 15, 2026
19w ago
144
NEUTRAL ★ 2/10
$12.21 $12.20▼ −0.08%▲ +0.51%$29.82 (+144.23%)
Jun 15, 2026
19w ago
144
NEUTRAL ★ 2/10
$12.21 $12.20▼ −0.08%▲ +0.51%$29.82 (+144.23%)
May 6, 2026
25w ago
8-K
BEARISH ★ 7/10
$12.31 $12.31· 0.00%▲ +0.83%$29.82 (−142.24%)
May 5, 2026
25w ago
8-K
BULLISH ★ 7/10
$12.85 $13.01▲ +1.25%▼ −0.14%$29.82 (+132.06%)
Apr 27, 2026
26w ago
8-K
NEUTRAL ★ 3/10
$12.15 $11.64▼ −4.20%▼ −4.19%$29.82 (+145.43%)
Showing 10 of 13

US Market Status

Market Closed · Opens Mon (23h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026